Preventive Effect of Clostridium Butyricum MIYAIRI Against Pouchitis in Children with Ulcerative Colitis

Overview

Journal Surg Today

Specialty General Surgery

Date 2024 Dec 24

PMID 39718596

Authors

Yuhki Koike

Koki Higashi

Yuki Sato

Shinji Yamashita

Yuka Nagano

Tadanobu Shimura

Takahito Kitajima

Kohei Matsushita

Yoshinaga Okugawa

Yoshiki Okita

Mikihiro Inoue

Keiichi Uchida

Yuji Toiyama

Affiliations

Soon will be listed here.

Abstract

Purpose: Pouchitis is a major complication after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis in children (UCc). In this study, we investigated whether the oral administration of Clostridium butyricum MIYAIRI 588 (CBM) can reduce the incidence of pouchitis after IPAA in UCc.

Methods: We reviewed the data for pediatric patients with UC, who underwent IPAA in Mie University Hospital between 2004 and 2022. Data on the presence and type of postoperative probiotic medication and the timing of probiotic initiation, as well as clinical variables, were collected from the patients' medical records.

Results: During the study period, 55 children with UC underwent radical surgery. During the first 5 years after ileostomy closure, 23 (41.8%) patients suffered at least one pouchitis episode. The incidence of acute pouchitis was significantly lower in the CBM group than in the non-CBM group (CBM vs. non-CBM: 10.5% vs. 58.3%, p < 0.01). Furthermore, even among patients who had been taking any probiotics postoperatively, the CBM group had a significantly lower incidence of both acute and chronic pouchitis than the 'other probiotics' group (p < 0.01).

Conclusion: Oral CBM administration after ileostomy closure may be effective in preventing postoperative pouchitis.

References

Jakobsen C, Bartek Jr J, Wewer V, Vind I, Munkholm P, Groen R . Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study. Aliment Pharmacol Ther. 2011; 34(10):1217-24. DOI: 10.1111/j.1365-2036.2011.04857.x. View

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View

Shen B, Fazio V, Remzi F, Delaney C, Bennett A, Achkar J . Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol. 2005; 100(1):93-101. DOI: 10.1111/j.1572-0241.2005.40778.x. View

Coffey J, Winter D, Neary P, Murphy A, Redmond H, Kirwan W . Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum. 2002; 45(1):30-8. View

Shen B . Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol. 2012; 9(6):323-33. DOI: 10.1038/nrgastro.2012.58. View

Ferrante M, Declerck S, Coopmans T, De Hertogh G, Van Assche G, Penninckx F . Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes. J Crohns Colitis. 2010; 2(2):142-51. DOI: 10.1016/j.crohns.2007.10.003. View

Wewer V, Hesselfeldt P, Qvist N, Husby S, Paerregaard A . J-pouch ileoanal anastomosis in children and adolescents with ulcerative colitis: functional outcome, satisfaction and impact on social life. J Pediatr Gastroenterol Nutr. 2005; 40(2):189-93. DOI: 10.1097/00005176-200502000-00020. View

Chew S, Kerdic R, Yang J, Shi E, Newstead G, Douglas P . Functional outcome and quality of life after ileal pouch-anal anastomosis in children and adults. ANZ J Surg. 2003; 73(12):983-7. DOI: 10.1046/j.1445-2197.2003.t01-5-.x. View

Alexander F, Sarigol S, DiFiore J, Stallion A, Cotman K, Clark H . Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg. 2003; 38(1):78-82. DOI: 10.1053/jpsu.2003.50015. View

10.

Sarigol S, Wyllie R, Gramlich T, Alexander F, Fazio V, Kay M . Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr. 1999; 28(4):429-34. DOI: 10.1097/00005176-199904000-00015. View

11.

Drews J, Onwuka E, Fisher J, Huntington J, Dutkiewicz M, Nogalska A . Complications after proctocolectomy and ileal pouch-anal anastomosis in pediatric patients: A systematic review. J Pediatr Surg. 2018; 54(7):1331-1339. DOI: 10.1016/j.jpedsurg.2018.08.047. View

12.

Hayashi A, Sato T, Kamada N, Mikami Y, Matsuoka K, Hisamatsu T . A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe. 2013; 13(6):711-22. DOI: 10.1016/j.chom.2013.05.013. View

13.

Hagihara M, Kuroki Y, Ariyoshi T, Higashi S, Fukuda K, Yamashita R . Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis. iScience. 2020; 23(1):100772. PMC: 6970176. DOI: 10.1016/j.isci.2019.100772. View

14.

Imase K, Takahashi M, Tanaka A, Tokunaga K, Sugano H, Tanaka M . Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota. Microbiol Immunol. 2008; 52(3):156-61. DOI: 10.1111/j.1348-0421.2008.00026.x. View

15.

Sun Y, Li M, Li Y, Li L, Zhai W, Wang P . The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Sci Rep. 2018; 8(1):2964. PMC: 5813237. DOI: 10.1038/s41598-018-21241-z. View

16.

Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M . Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clin Neuropharmacol. 2018; 41(5):151-155. DOI: 10.1097/WNF.0000000000000299. View

17.

Yasueda A, Mizushima T, Nezu R, Sumi R, Tanaka M, Nishimura J . The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surg Today. 2015; 46(8):939-49. DOI: 10.1007/s00595-015-1261-9. View

18.

Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A . Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7368581. DOI: 10.1136/bmjdrc-2020-001319. View

19.

Sanchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordonez R, Medina J . The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response. Cancers (Basel). 2020; 12(6). PMC: 7352899. DOI: 10.3390/cancers12061406. View

20.

Stoeva M, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M . Butyrate-producing human gut symbiont, , and its role in health and disease. Gut Microbes. 2021; 13(1):1-28. PMC: 8078720. DOI: 10.1080/19490976.2021.1907272. View